CG Invites Co., Ltd. (KOSDAQ:083790)
 1,497.00
 -33.00 (-2.16%)
  Oct 31, 2025, 3:30 PM KST
CG Invites Revenue
CG Invites had revenue of 6.18B KRW in the quarter ending June 30, 2025, with 183.42% growth. This brings the company's revenue in the last twelve months to 13.62B, up 198.88% year-over-year. In the year 2024, CG Invites had annual revenue of 7.25B with 48.67% growth.
Revenue (ttm) 
 13.62B
Revenue Growth 
 +198.88%
P/S Ratio 
 8.64
Revenue / Employee 
 156.59M
Employees 
 87
Market Cap 
117.65B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 7.25B | 2.37B | 48.67% | 
| Dec 31, 2023 | 4.88B | 557.33M | 12.90% | 
| Dec 31, 2022 | 4.32B | -38.05B | -89.80% | 
| Dec 31, 2021 | 42.38B | 12.15B | 40.21% | 
| Dec 31, 2020 | 30.22B | 16.22B | 115.78% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| Samsung Biologics | 5.03T | 
| Celltrion | 3.75T | 
| Yuhan | 2.17T | 
| SK Biopharmaceuticals | 620.28B | 
| PharmaResearch | 449.81B | 
| Sam Chun Dang Pharm. | 215.10B | 
| ALTEOGEN | 158.06B | 
| LigaChem Biosciences | 148.28B |